These results can provide data support for the study of the antitumor effect of TCMs and their potential in alleviating diarrhea as an adverse reaction to EGFR-TKI treatment in the future and provide a basis for exploring TCM combined with EGFR-TKI in the treatment of NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.